132 related articles for article (PubMed ID: 1827401)
1. Improvement in the regulation of cellular cholesterologenesis in diabetes: the effect of reduction in serum cholesterol by simvastatin.
Owens D; Stinson J; Collins P; Johnson A; Tomkin GH
Diabet Med; 1991; 8(2):151-6. PubMed ID: 1827401
[TBL] [Abstract][Full Text] [Related]
2. Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms.
Owens D; Collins P; Johnson A; Tighe O; Robinson K; Tomkin GH
Biochim Biophys Acta; 1991 Apr; 1082(3):303-9. PubMed ID: 1903069
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
[TBL] [Abstract][Full Text] [Related]
4. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
van Deursen RT; Nieuwenhuijzen Kruseman AC; Degenaar CP; Wolffenbuttel BH
Ned Tijdschr Geneeskd; 1990 Nov; 134(44):2142-6. PubMed ID: 2247172
[TBL] [Abstract][Full Text] [Related]
5. Hypercholesterolemia in non-insulin-dependent diabetes mellitus: different effect of simvastatin on VLDL and LDL cholesterol levels.
Cassader M; Ruiu G; Gambino R; Alemanno N; Veglia F; Pagano G
Atherosclerosis; 1993 Feb; 99(1):47-53. PubMed ID: 8461059
[TBL] [Abstract][Full Text] [Related]
6. Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria.
Nielsen S; Schmitz O; Møller N; Pørksen N; Klausen IC; Alberti KG; Mogensen CE
Diabetologia; 1993 Oct; 36(10):1079-86. PubMed ID: 8243858
[TBL] [Abstract][Full Text] [Related]
7. The effects of simvastatin on plasma lipoproteins and cholesterol homeostasis in patients with heterozygous familial hypercholesterolaemia.
Hagemenas FC; Pappu AS; Illingworth DR
Eur J Clin Invest; 1990 Apr; 20(2):150-7. PubMed ID: 2112479
[TBL] [Abstract][Full Text] [Related]
8. Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures.
Farrer M; Winocour PH; Evans K; Neil HA; Laker MF; Kesteven P; Alberti KG
Diabetes Res Clin Pract; 1994 Mar; 23(2):111-9. PubMed ID: 8070302
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin treatment of hypercholesterolemia in patients with insulin dependent diabetes mellitus.
Sartor G; Katzman P; Eizyk E; Kalén J; Nilsson A; Ugander L; Ursing D
Int J Clin Pharmacol Ther; 1995 Jan; 33(1):3-6. PubMed ID: 7711988
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin in non-insulin-dependent diabetic patients with hypercholesterolaemia.
Steyn K; Weich HF; Bonnici F; Kotze TJ; Stander I; Vermaak WJ; Lourens W; van Lathem J; Omar MA; Fourie J
S Afr Med J; 1992 Dec; 82(6):402-6. PubMed ID: 1465688
[TBL] [Abstract][Full Text] [Related]
11. A 6-month trial of simvastatin (HMG-CoA reductase inhibitor) in the treatment of hypercholesterolaemia.
Steyn K; Weich HF; Vermaak WJ; Marais AD; Omar MA; Van Gelder AL; Fourie J; Kotze TJ; Stander I; Firth JC
S Afr Med J; 1991 Jun; 79(11):639-45. PubMed ID: 2047945
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.
Hommel E; Andersen P; Gall MA; Nielsen F; Jensen B; Rossing P; Dyerberg J; Parving HH
Diabetologia; 1992 May; 35(5):447-51. PubMed ID: 1521727
[TBL] [Abstract][Full Text] [Related]
14. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens.
Mosley ST; Kalinowski SS; Schafer BL; Tanaka RD
J Lipid Res; 1989 Sep; 30(9):1411-20. PubMed ID: 2513368
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin in severe primary hypercholesterolemia: efficacy, safety, and tolerability in 595 patients over 18 weeks. The Principal Investigators.
Simons LA
Clin Cardiol; 1993 Apr; 16(4):317-22. PubMed ID: 8458112
[TBL] [Abstract][Full Text] [Related]
16. Effect of low-dose simvastatin on cholesterol levels, oxidative susceptibility, and antioxidant levels of low-density lipoproteins in patients with hypercholesterolemia: a pilot study.
Yoshida H; Ishikawa T; Ayaori M; Shige H; Hosoai H; Nishio E; Tomiyasu K; Yamashita T; Suzukawa M; Nishiwaki M
Clin Ther; 1995; 17(3):379-89. PubMed ID: 7585842
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patients.
Lansberg PJ; Mitchel YB; Shapiro D; Kastelein JJ; Altman R; Jerums G; Bolzano K; Giannini S; Davignon J; DeWailly P
Atherosclerosis; 1995 Aug; 116(2):153-62. PubMed ID: 7575771
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
Mölgaard J; von Schenck H; Olsson AG
Eur J Clin Pharmacol; 1989; 36(5):455-60. PubMed ID: 2502417
[TBL] [Abstract][Full Text] [Related]
19. Treatment with hydroxymethylglutaryl-coenzyme A reductase inhibitors in hypercholesterolemia induces changes in the components of the extrinsic coagulation system.
Sandset PM; Lund H; Norseth J; Abildgaard U; Ose L
Arterioscler Thromb; 1991; 11(1):138-45. PubMed ID: 1987991
[TBL] [Abstract][Full Text] [Related]
20. Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
O'Brien RC; Simons LA; Clifton P; Cooper ME; Jennings GL; Jerums G; Nestel PJ; Sullivan D
Med J Aust; 1990 May; 152(9):480-3. PubMed ID: 2199801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
